EDOLYNX Trademark

Trademark Overview

On Monday, November 22, 2010, a trademark application was filed for EDOLYNX with the United States Patent and Trademark Office. The USPTO has given the EDOLYNX trademark a serial number of 85182492. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 14, 2014. This trademark is owned by Glaxo Group Limited. The EDOLYNX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
edolynx

General Information

Serial Number85182492
Word MarkEDOLYNX
Filing DateMonday, November 22, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 14, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 27, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, July 14, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 14, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 4, 2013EXTENSION 5 GRANTED
Monday, December 2, 2013EXTENSION 5 FILED
Monday, December 2, 2013TEAS EXTENSION RECEIVED
Wednesday, June 26, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2013EXTENSION 4 GRANTED
Wednesday, May 29, 2013EXTENSION 4 FILED
Tuesday, June 25, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 29, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, December 1, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 30, 2012EXTENSION 3 GRANTED
Tuesday, November 27, 2012EXTENSION 3 FILED
Tuesday, November 27, 2012TEAS EXTENSION RECEIVED
Wednesday, June 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 19, 2012EXTENSION 2 GRANTED
Thursday, May 24, 2012EXTENSION 2 FILED
Tuesday, June 19, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 24, 2012TEAS EXTENSION RECEIVED
Thursday, November 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 15, 2011EXTENSION 1 GRANTED
Tuesday, November 15, 2011EXTENSION 1 FILED
Tuesday, November 15, 2011TEAS EXTENSION RECEIVED
Tuesday, June 7, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 12, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2011PUBLISHED FOR OPPOSITION
Saturday, March 5, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 2, 2011ASSIGNED TO EXAMINER
Saturday, November 27, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 25, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

edolynx pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological